CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- 8-K Event Material agreement · Unregistered share sale · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 8-K Event Material agreement · Agreement ended · Unregistered share sale · Shareholder rights changed · Executive or director change · Other events
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation · Delisting notice · Unregistered share sale · Shareholder rights changed · Other events
- 8-K Event Results of operations · Executive or director change
- 10-K Report Annual Report
- 8-K Event Unregistered share sale
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 8-K Event Material agreement · Delisting notice
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Other events
Page 8 of 11 · 206 filings